Who
Elizabeth Mily
Director
Company insider
Files Form 4 as: Director, Solventum; EVP, Strategy & BD, Bristol-Myers Squibb.
In numbers
- Trades disclosed
- 61
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 1 Apr 2020
- Last trade
- 15 May 2026
- Last filed
- 18 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 May 2026filed 18 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,300 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,300 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | SOLV SolventumMedical Devices | SEC FORM 4 Code M | —3,403 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,403 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,403 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | SOLV SolventumMedical Devices | SEC FORM 4 Code M | —3,403 at $0.00 | filing |
| 27 Mar 2026filed 30 Mar 2026 | SOLV SolventumMedical Devices | SEC FORM 4 Code M | —1,980 at $0.00 | filing |
| 27 Mar 2026filed 30 Mar 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,980 at $0.00 | filing |
| 27 Mar 2026filed 30 Mar 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,980 at $0.00 | filing |
| 27 Mar 2026filed 30 Mar 2026 | SOLV SolventumMedical Devices | SEC FORM 4 Code M | —1,980 at $0.00 | filing |
| 13 May 2025filed 15 May 2025 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,564 at $0.00 | filing |
| 13 May 2025filed 15 May 2025 | SOLV SolventumMedical Devices | SEC FORM 4 Code M | —3,564 at $0.00 | filing |
| 30 Apr 2025filed 2 May 2025 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,403 at $0.00 | filing |
| 13 May 2024filed 15 May 2024 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,564 at $0.00 | filing |
| 13 May 2024filed 15 May 2024 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,980 at $0.00 | filing |
| 1 Apr 2023filed 4 Apr 2023 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —3,662 at $0.00 | filing |
| 1 Apr 2023filed 4 Apr 2023 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,684 at $0.00 | filing |
| 1 Apr 2023filed 4 Apr 2023 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code M | —3,662 at $0.00 | filing |
| 1 Apr 2023filed 4 Apr 2023 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code J | —1,190 at $0.00 | filing |
| 1 Apr 2023filed 4 Apr 2023 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code F | $143K2,059 at $69.31 | filing |
News
Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directorsmanilatimes.net · 1 Oct 2026
1 headline in the last 90 days name Elizabeth Mily; no company of theirs resolves to a name we track.
Sectors
No trade we could place in a sector.